Gao et al. (174, 175) suggested that SIK2 then in turn drives glycolysis by upregulating the expression of transcription factor hypoxia-inducible factor-1α (HIF-1α), which modulates the adaptation of cancer cells to hypoxic environments. The gene discussed is SIK2; the disease is cancer.